Magnolia Capital Advisors LLC Invests $783,000 in Synopsys, Inc. $SNPS

Magnolia Capital Advisors LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,755 shares of the semiconductor company’s stock, valued at approximately $783,000.

Several other hedge funds have also recently added to or reduced their stakes in the company. American Capital Management Inc. purchased a new stake in Synopsys during the 2nd quarter valued at about $8,563,000. Caisse de depot et placement du Quebec acquired a new position in shares of Synopsys during the 2nd quarter worth approximately $110,382,000. Advent International L.P. purchased a new stake in shares of Synopsys in the second quarter valued at approximately $33,676,000. Man Group plc acquired a new stake in shares of Synopsys in the second quarter valued at approximately $55,900,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Synopsys in the second quarter valued at approximately $108,799,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This represents a 19.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by insiders.

Synopsys Stock Performance

Shares of Synopsys stock opened at $410.00 on Thursday. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $615.79. The business’s fifty day simple moving average is $416.71 and its 200-day simple moving average is $439.84. The firm has a market cap of $78.51 billion, a PE ratio of 94.91, a price-to-earnings-growth ratio of 2.40 and a beta of 1.23. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period last year, the company earned $3.39 EPS. The company’s quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys reported fiscal Q3 revenue of $2.477 billion, up 42.4% year over year, while non-GAAP EPS of $3.91 exceeded the $3.67 consensus estimate. Design Automation was the primary contributor, indicating broad demand for chip-design software. Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026
  • Positive Sentiment: Management raised its fiscal 2026 outlook to approximately $9.715 billion in revenue and $15.07 in non-GAAP EPS at the midpoints. The company also projected fourth-quarter EPS of $4.10-$4.16, above the $3.78 analyst consensus, citing continued AI-driven demand and benefits from the Ansys business. Synopsys raises annual forecasts on AI-driven chip design software demand
  • Positive Sentiment: Synopsys continues to position AI as a growth driver, saying customers are achieving substantial productivity gains and that engineering workflows are moving toward more autonomous systems. Nvidia’s reported $2 billion investment in Synopsys also reinforces the strategic importance of AI-powered design and simulation. Nvidia’s $2 Billion Synopsys Bet Signals AI’s Next Frontier
  • Neutral Sentiment: Analyst sentiment remains favorable: Rosenblatt reaffirmed a Buy rating and set a $575 price target. However, SNPS trades at a high earnings multiple, leaving the shares sensitive to guidance, execution and valuation concerns. Rosenblatt Reiterates Buy Rating on Synopsys
  • Negative Sentiment: The stock declined even after the earnings beat and guidance increase. The reaction indicates that strong results may already have been priced in, while full-year revenue guidance was broadly aligned with expectations and fourth-quarter revenue guidance of $2.53-$2.58 billion did not clearly exceed consensus. Synopsys slides even as it boosts full-year guidance

Analysts Set New Price Targets

SNPS has been the topic of a number of recent research reports. Morgan Stanley lowered their price objective on Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 19th. Robert W. Baird set a $558.00 price target on Synopsys in a report on Thursday, May 28th. KeyCorp reissued an “overweight” rating on shares of Synopsys in a research report on Wednesday, August 19th. Stifel Nicolaus upped their price objective on shares of Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, Rosenblatt Securities restated a “buy” rating and set a $575.00 price objective on shares of Synopsys in a research report on Tuesday. Eleven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and a consensus target price of $563.59.

View Our Latest Report on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.